Research programme: HIV infection therapeutics - Fox Chase Chemical Diversity Center/ Drexel University
Latest Information Update: 05 Sep 2023
Price :
$50 *
At a glance
- Originator Drexel University College of Medicine; Fox Chase Chemical Diversity Center
- Class
- Mechanism of Action Dendritic cell inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 05 Sep 2023 Discontinued - Preclinical for HIV infections in USA (unspecified route)
- 28 Aug 2020 No recent reports of development identified for preclinical development in HIV-infections in USA
- 04 Jul 2016 Preclinical trials in HIV infections in USA (unspecified route)